6 Recruiting Medulloblastoma Phase 2 Clinical Trials
Active phase 2 studies for medulloblastoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Medulloblastoma studiesPhase 2 Studies for Medulloblastoma
🔵 Active, Not Recruiting Phase2
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
📍 Lucille Packard Children's Hospital at Stanford University Medical Center — Palo Alto, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔ 🟢 Recruiting Phase2
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
📍 Lucille Packard Children's Hospital Stanford — Palo Alto, California
View Study & Checklist ➔ 🟢 Recruiting Phase2
Digoxin Medulloblastoma Study
📍 University of Alabama at Birmingham Children's of Alabama — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
📍 Arkansas Children's Hospital — Little Rock, Arkansas
View Study & Checklist ➔